AR229931A1 - Procedimiento para producir interferon de fibroblasto humano esencialmente purificado como proteina homogenea - Google Patents

Procedimiento para producir interferon de fibroblasto humano esencialmente purificado como proteina homogenea

Info

Publication number
AR229931A1
AR229931A1 AR282016A AR28201680A AR229931A1 AR 229931 A1 AR229931 A1 AR 229931A1 AR 282016 A AR282016 A AR 282016A AR 28201680 A AR28201680 A AR 28201680A AR 229931 A1 AR229931 A1 AR 229931A1
Authority
AR
Argentina
Prior art keywords
procedure
purified human
human fibroblast
produce interferon
essentially purified
Prior art date
Application number
AR282016A
Other languages
English (en)
Spanish (es)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of AR229931A1 publication Critical patent/AR229931A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/565IFN-beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AR282016A 1979-07-31 1980-07-31 Procedimiento para producir interferon de fibroblasto humano esencialmente purificado como proteina homogenea AR229931A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6237179A 1979-07-31 1979-07-31
US13063580A 1980-03-14 1980-03-14

Publications (1)

Publication Number Publication Date
AR229931A1 true AR229931A1 (es) 1984-01-31

Family

ID=26742182

Family Applications (1)

Application Number Title Priority Date Filing Date
AR282016A AR229931A1 (es) 1979-07-31 1980-07-31 Procedimiento para producir interferon de fibroblasto humano esencialmente purificado como proteina homogenea

Country Status (33)

Country Link
US (1) US5015730A (fi)
JP (1) JPH02138226A (fi)
AR (1) AR229931A1 (fi)
AT (1) AT372387B (fi)
AU (1) AU536274B2 (fi)
CA (1) CA1146468A (fi)
CH (1) CH648331A5 (fi)
DE (1) DE3028919A1 (fi)
DK (1) DK159825C (fi)
DO (1) DOP1980002948A (fi)
ES (1) ES493849A0 (fi)
FI (1) FI70721C (fi)
FR (1) FR2462167B1 (fi)
GB (1) GB2055384B (fi)
HK (1) HK40384A (fi)
HU (1) HU185382B (fi)
IE (1) IE50075B1 (fi)
IL (1) IL60697A (fi)
IT (1) IT1132269B (fi)
KE (1) KE3364A (fi)
LU (1) LU82673A1 (fi)
MC (1) MC1337A1 (fi)
MY (1) MY8500274A (fi)
NL (1) NL8004361A (fi)
NO (1) NO151158C (fi)
NZ (1) NZ194495A (fi)
PH (2) PH17738A (fi)
PT (1) PT71625B (fi)
RO (1) RO81474B (fi)
SE (1) SE466290B (fi)
YU (1) YU193480A (fi)
ZA (1) ZA803943B (fi)
ZW (1) ZW17980A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE57069B1 (en) 1980-04-03 1992-04-22 Biogen Inc Dna sequences,recombinant dna molecules and processes for producing human fibroblast interferon
IT1139487B (it) * 1980-09-25 1986-09-24 Genentech Inc Produzione microbica di interferone di fibroblasti umani
ZA83768B (en) * 1982-03-01 1983-10-26 Hoffmann La Roche Homogeneous human immune interferon and process therefor
US4966843A (en) * 1982-11-01 1990-10-30 Cetus Corporation Expression of interferon genes in Chinese hamster ovary cells
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
US4894330A (en) * 1986-12-23 1990-01-16 Cetus Corporation Purification of recombinant beta-interferon incorporating RP-HPLC
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US20050002902A1 (en) * 1995-12-28 2005-01-06 Liming Yu Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
US20030026779A1 (en) * 1999-10-15 2003-02-06 Liming Yu Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
BRPI0520498B8 (pt) 2005-08-26 2021-05-25 Ares Trading Sa processo para fabricação de interferon beta humano recombinante glicosilado, e uso de um meio de cultura isento de soro
US8604175B2 (en) 2005-12-09 2013-12-10 Ares Trading S.A. Method for purifying FSH or a FSH mutant
US20100249381A1 (en) * 2007-10-22 2010-09-30 David Delvaille Method for Purifying FC-Fusion Proteins
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta

Also Published As

Publication number Publication date
FR2462167A1 (fr) 1981-02-13
MC1337A1 (fr) 1981-04-21
NO151158B (no) 1984-11-12
HK40384A (en) 1984-05-18
CH648331A5 (de) 1985-03-15
FI70721B (fi) 1986-06-26
AU6091480A (en) 1981-02-05
NO802297L (no) 1981-02-02
DE3028919C2 (fi) 1988-02-18
NZ194495A (en) 1984-07-31
PH17738A (en) 1984-11-23
KE3364A (en) 1984-02-03
HU185382B (en) 1985-01-28
DK159825C (da) 1991-04-29
GB2055384A (en) 1981-03-04
NL8004361A (nl) 1981-02-03
PT71625B (en) 1981-12-17
NO151158C (no) 1985-02-20
FI802400A (fi) 1981-02-01
MY8500274A (en) 1985-12-31
IL60697A (en) 1984-04-30
IT1132269B (it) 1986-07-02
FI70721C (fi) 1986-10-06
LU82673A1 (fr) 1982-02-17
IE50075B1 (en) 1986-02-05
FR2462167B1 (fr) 1985-07-05
GB2055384B (en) 1983-08-10
AU536274B2 (en) 1984-05-03
RO81474B (ro) 1983-04-30
ZA803943B (en) 1981-06-24
SE8005498L (sv) 1981-02-01
AT372387B (de) 1983-09-26
RO81474A (ro) 1983-04-29
ES8200560A1 (es) 1981-11-16
YU193480A (en) 1984-04-30
DE3028919A1 (de) 1981-02-19
SE466290B (sv) 1992-01-27
IE801589L (en) 1981-01-31
DOP1980002948A (es) 1989-04-20
PH18479A (en) 1985-07-18
US5015730A (en) 1991-05-14
PT71625A (en) 1980-08-01
JPH02138226A (ja) 1990-05-28
IL60697A0 (en) 1980-09-16
DK159825B (da) 1990-12-10
ES493849A0 (es) 1981-11-16
CA1146468A (en) 1983-05-17
ZW17980A1 (en) 1981-03-18
DK328880A (da) 1981-02-01
IT8023801A0 (it) 1980-07-30
ATA395080A (de) 1983-02-15

Similar Documents

Publication Publication Date Title
AR229931A1 (es) Procedimiento para producir interferon de fibroblasto humano esencialmente purificado como proteina homogenea
ES490697A0 (es) Un metodo de producir proteinas de interferon humano de for-ma le
DK478786D0 (da) Cystein-forarmede muteiner af biologisk aktive humantumornekrosefaktorproteiner
FR2490675B1 (fr) Production microbienne d'interferon de fibroplaste humain
IT1127253B (it) Proteine purificate e procedimento per la loro preparazione
BR8004094A (pt) Fralda descartavel
ES491432A0 (es) Procedimiento para obtener agentes de tratamiento de fibras queratinicas
DK154045C (da) Engangsble
SE7800843L (sv) Till polyamid fixerat biologiskt aktivt protein och forfarande for dess framstellning
BR8003841A (pt) Quadro de comutacao encoberto
AR227021A1 (es) Procedimiento de preparacion de concentrados de complejo protrombinico altamente purificado
ES535509A0 (es) Procedimiento para purificar interferon de humano
IT1036478B (it) Procedimento ed impianto per la fabricazione di libri cuciti
SE7805026L (sv) Aminohartskomposition i formfibrer
BR8007022A (pt) Fralda descartavel
DK31386D0 (da) Behandling af proliferative hudsygdomme
ES543524A0 (es) Procedimiento para preparar benzoxazolil- y benzotiazolil- aminoacidos
MX14287A (es) Procedimiento para preparar acidos oxoftalazinil-aceticos heterociclicos
AR229097A1 (es) Imidas de acidos succinicos y procedimiento para prepararlas
MX5066E (es) Procedimiento mejorado para la elaboracion de piridina y 3-metilpiridina
IT1098014B (it) Separazione di aminoacidi in antipodi ottici
AT361617B (de) Gewinnung und reinigung von humaninterferon
IT1192563B (it) Composizione per il trattamento di malattie allergiche
IT1133086B (it) Preparato medicinale per trattare carcinomi e procedimento per la sua produzione
JPS5622794A (en) Human fibroblast interferon